Cargando…
Letter to the Editor: “Use of inhaled epoprostenol with high flow nasal oxygen in non-intubated patients with severe COVID-19”
PURPOSE: Acute lung injury associated with COVID-19 contributes significantly to its morbidity and mortality. Though invasive mechanical ventilation is sometimes necessary, the use of high flow nasal oxygen may avoid the need for mechanical ventilation in some patients. For patients approaching the...
Autores principales: | Chiles, Joe W., Vijaykumar, Kadambari, Darby, Adrienne, Goetz, Ryan L., Kane, Lauren E., Methukupally, Abhishek R., Gandotra, Sheetal, Russell, Derek W., Whitson, Micah R., Kelmenson, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863404/ https://www.ncbi.nlm.nih.gov/pubmed/35217371 http://dx.doi.org/10.1016/j.jcrc.2022.153989 |
Ejemplares similares
-
Prolonged Prone Positioning for COVID-19–induced Acute Respiratory Distress Syndrome: A Randomized Pilot Clinical Trial
por: Page, David B., et al.
Publicado: (2022) -
HIGH-FLOW NASAL CANULA AND INHALED EPOPROSTENOL RESPONSE IN COVID-19
por: KHURANA, NEHARIKA, et al.
Publicado: (2022) -
Effects of Inhaled Epoprostenol and Prone Positioning in Intubated Coronavirus Disease 2019 Patients With Refractory Hypoxemia
por: Li, Jie, et al.
Publicado: (2020) -
In-vitro and in-vivo comparisons of high versus low concentrations of inhaled epoprostenol to adult intubated patients
por: Li, Jie, et al.
Publicado: (2021) -
Successful use of inhaled epoprostenol as rescue therapy for pediatric ARDS
por: Urich, Alissa, et al.
Publicado: (2020)